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IMPORTANCE Novel methods of detecting eye disease are needed due to the challenges 
associated with service delivery in resource-limited settings. 
 
BACKGROUND The objective of this study is to determine whether clinically gradable 
fundus images can be obtained using a low-cost, handheld non-mydriatic fundus camera by 
a non-ophthalmic provider in a remote setting.  
 
DESIGN Cross-sectional study  
 
PARTICIPANTS Two-hundred and six individuals (412 eyes) in the Pacific Island nation of 
Samoa with pre-diabetes and diabetes (HbA1c ≥5.7% or FBG ≥110 mg/dl).  
 
METHODS Participants underwent non-mydriatic fundus photography with the PanOptic 
iExaminer System, along with an assessment of near vision, medical, and ophthalmic 
histories. Images were remotely graded by an ophthalmologist and optometrist, who were 
blinded to participants’ demographic and biometric data.  
 
MAIN OUTCOME MEASURES The percentage of clinically gradable images, positive 
findings, and degree of inter-rater reliability and agreeability among graders were measured.  
 
RESULTS Clinically gradable images were obtained from 337 eyes (81.8%). Positive 
findings were identified in 29.1% of participants: 7 participants (3.4%) had non-proliferative 
diabetic retinopathy, 19 participants (9.2%) had evidence of background retinopathy, 33 
participants (16.0%) had features of glaucoma, and 10 participants (4.9%) had other lesions, 
tumors, or structural abnormalities. Those with positive findings were referred for expedited 
review by a local ophthalmologist.  
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CONCLUSION AND RELEVANCE Positive ophthalmic findings, including features of 
diabetic retinopathy and glaucoma, were readily identified in individuals at risk for 
undiagnosed eye disease screened with the PanOptic iExaminer. Use of smartphone-based 
remote screening holds promise as a cost-effective public health intervention in resource-
constrained settings. 
 
KEY WORDS: Chronic Disease Epidemiology, Retinal-Imaging, Telemedicine, 
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INTRODUCTION   
 
Screening for vision-threatening conditions represents a significant challenge to 
improving eye care in resource-constrained settings. Low- to middle-income countries 
(LMICs) are disproportionately burdened by several chronic conditions, including diabetes,1  
placing these populations at significant risk for microvascular and macrovascular 
complications.2 The number of individuals with visual impairment and blindness due to 
diabetic retinopathy continues to rise worldwide,3 even though timely detection and 
treatment has the potential to reduce permanent vision loss4 or even restore central vision in 
many cases.5 Despite international guidelines and recommended best practices that 
promote an annual ophthalmic examination for patients with diabetes mellitus,6 only 50-60% 
of people in high-income countries complete such screening.7 Globally, only 7.4-13% of 
people in LMICs undergo screening due to cost, knowledge, and access issues.8 Novel 
methods that address the challenges of limited personnel and lack of expensive ophthalmic 
equipment may reduce avoidable vision loss, but their ability to identify visually significant 
eye disease remains poorly defined.  
 
The advent of smartphone-based non-mydriatic fundus cameras allows for highly 
mobile, cost-effective screening programs capable of reaching remote and underserved 
areas.9-14 Screening with ophthalmoscopes and other portable devices can be performed 
quickly and inexpensively by trained providers.15,16 Recent advances in imaging and 
communication technologies have expanded the use of ocular telehealth programs,17,18 and 
handheld, battery-operated devices have ameliorated challenges associated with fundus 
photography outside of the traditional clinic.19 For example, diabetic retinopathy screening 
camps in rural India have identified sight-threatening retinopathy in nearly 7% of the 
population and referred patients for further treatment.20 Unfortunately, access to trained 
providers to staff such outreach efforts remains in short supply. 
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While ocular telehealth programs have revealed that digital images can be procured 
by non-ophthalmic providers with reasonable specificity and sensitivity,19, 20-23 few studies 
have explored the potential for remote diagnosis using more portable, lower-cost 
instruments.24 Furthermore, no study to date has undertaken a diabetic screening program 
in the Pacific, a region facing some of the highest rates of diabetes globally.25 To address 
these knowledge gaps, we piloted a low-cost, smartphone-based remote retinal diagnosis 
system to screen for ocular complications in Samoa, a LMIC population with a high 
prevalence of diabetes and low access to ophthalmology services. Our objective was to 
determine the percentage of gradable images that could be obtained using the PanOptic 
iExaminer System (Welch Allyn Inc., NY) and to determine whether this device could be 
used to successfully screen for diabetic retinopathy and other eye conditions in a high-risk 




Study Design and Setting  
 
The study took place in the independent Pacific Island nation of Samoa. As a result 
of recent epidemiologic transition, nearly 47% of Samoan adults have diabetes and >80% 
are overweight/obese.26-29 Individual control of diabetes and management of retinal 
complications is a challenge for the Pacific Islands, where limited equipment and uncertain 
supply chains for diagnostics make glucose monitoring difficult.30 Geographic isolation from 
Hawaii and New Zealand (each more than 2000 miles away) requires that most residents 
receive care in Samoa, where only one full-time ophthalmologist serves a population of 
nearly 200,000 people.31 
 
The present study was undertaken alongside an ongoing longitudinal study of the 
genetics of obesity and diabetes among Samoans: the Samoan Obesity, Lifestyle, and 
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Genetic Adaptation Group’s Soifua Manuia (“Good Health”) study. A village-based screening 
of a convenience sample of approximately 700 Samoan adults (Samoan ethnicity based on 
four Samoan grandparents) was conducted in 12 urban and peri-urban villages between 
June and August 2018, focusing on individuals between the ages of 30.5 and 50 years. 
Exclusion criteria included pregnancy, use of weight loss medication, prior weight loss 
surgery, participation in a major diet or physical activity program, or a weight loss of >5% of 
total body weight in the past 12 months. Only one individual per family was selected to 
minimize relatedness among the samples.  
 
All participants were screened for glycosylated hemoglobin (HbA1c; A1c Now point-
of-care System [PTS Diagnostics, IN]), body mass index (BMI), and blood pressure (Omron 
HEM 907XL, Omron Healthcare, IL). Individuals >50 years of age who were ineligible for the 
larger study based on their age were also offered health screening, including a random 
finger-prick fasting blood glucose (Bayer Contour, NJ). All participants with pre-diabetes and 
diabetes (HbA1c ≥5.7% or FBG ≥110 mg/dl) were offered eye screening with the PanOptic 
iExaminer.  
 
Eye Examinations and Image Grading  
 
Participants underwent a non-mydriatic, bilateral eye examination using the PanOptic 
iExaminer attached to an iPhone 6S (Apple, Inc., CA). Similar to a direct ophthalmoscope, 
the device is a handheld instrument, but provides a five-fold larger view of the fundus than a 
standard ophthalmoscope (approximately 25° versus 5°). A 3.5V re-chargeable power 
handle was used to power the device in the field. The iExaminer is the only smartphone-
based imaging device with U.S. Food and Drug Administration (FDA) approval to date.32 
 
All examinations were performed outside of a traditional clinic in a village-based 
location by a health worker trained in the basics of eye examination, as well as in the use of 
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the PanOptic iExaminer (L.C.L.). Images were de-identified and submitted for remote review 
by an ophthalmologist trained in retina (D.J.R.) and an optometrist (M.K.B.) at Lahey 
Hospital & Medical Center in Peabody, MA. Graders were blinded to participants’ 
demographic and biometric data and evaluated each pair of eyes independently. The best 
available image for each eye was used to grade the overall quality of the field examination 
according to a 5-point scale based on the Feasibility of Non-mydriatic Ocular Fundus 
Photography (FOTO-ED) Studies.33-35 Any features likely related to diabetic retinopathy, e.g. 
retinal hemorrhages, or other abnormalities of the vasculature that could be attributed to 
diabetes and/or hypertension were defined broadly as “retinopathy.” Other lesions and 
abnormalities were identified based on clinical judgment. Due to the requirement of a clear 
view of the optic disc, only images with a grade of 3 or higher were considered adequate to 
grade the cup-to-disc ratio (CDR).24 Glaucoma suspect status was defined by a CDR in one 
or both eyes ³0.6 or a difference in CDR between the two eyes ³0.2.  
 
Visual Acuity Assessment 
 
Near visual acuity exams were conducted by a single lay examiner (LCL) with a 
Rosenbaum Pocket Vision Screener held at approximately 14 inches from the eye with and 
without correction as previous described.36,37 A visual acuity limitation was defined as an 
inability to achieve vision ≥20/40. As a part of the ophthalmic focused history, participants 
communicated any visual acuity or anatomic complaints.  
  
Informed Consent and Referral System  
 
 The majority of encounters were performed in English (nearly 90%), one of the two 
official languages of the Independent State of Samoa. All participants were offered the use 
of an interpreter, a Samoan research assistant fully versed in study procedures. No formal 
record of language preference was recorded for the purposes of this study. Participants 
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were provided detailed information about the study and the data collection protocols and 
gave additional informed consent for participation. Research protocols and the informed 
consent procedures were approved both by the Yale University Institutional Review Board 
and the Health Research Committee of the Samoan Ministry of Health. 
 
 All participants were informed about the importance of obtaining an annual 
comprehensive eye exam regardless of their screening results. An expedited referral to a 
local ophthalmologist was provided to any participant when any of the following conditions 
were met: (1) presence of a positive finding upon telemedicine screening; (2) an inability to 
obtain images; (3) a near visual acuity limitation of £20/40, and/or (4) a subjective report of a 
functional or anatomic impairment beyond the scope of the eye screening. Research 
assistants from the Soifua Manuia study provided letters to all participants in need of an 




 Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., NC). 
Data were analyzed independently by eye and subsequently by participant. For analysis of 
variance and chi-square analyses, a two-sided p<0.05 was considered to be the threshold of 
statistical significance. Cohen’s Kappa (κ) statistic was used to assess the interobserver 
agreement for glaucoma suspect status by participant. Cronbach’s alpha coefficient and the 
intraclass correlation coefficient (ICC) estimates and their 95% confidence intervals were 










User Experience  
 Several environmental factors impacted the use of the PanOptic iExaminer System: 
(1) electrical charging and battery-life of the device; (2) lighting; (3) stabilization of viewing 
distance; and (4) examination time and participant compliance. Fundus imaging was 
performed in traditional Samoan fales (open-sided houses). Electricity was unavailable at 
these examination sites, requiring overnight charging of the lithium-ion batteries to permit 
intermittent operation of the device for 10-12 hours in the field each day. Examining an 
undilated eye in outdoor daytime illumination leads to constriction of the pupil. To overcome 
this, curtains were hung to construct a “tent” to block light. By reducing ambient illumination, 
participants did not have to cover their fellow eye while being imaged. Additionally, the eye-
cup of the PanOptic iExaminer System is compressible, providing a flexible viewing 
distance, but makes it challenging to for examiners with limited direct ophthalmoscopy 
experience. Lastly, light from the device itself may be uncomfortable for many participants. 
The more experienced the examiner, the shorter the total time required for image capture, 
significantly enhancing participant comfort and compliance. Fewer than 1% of eligible 
participants declined eye screening. 
 
Clinical Characteristics 
The mean age of participants was 45.4 ± 9.1 years, and 61.27% (n=125) were 
female (Table 1). Mean A1c was 7.48 ± 2.16%, and mean fasting blood glucose was 315.78 
± 116.31 mg/dl. Within our sample, 48 (23.41%) participants had a prior diabetes diagnosis, 
and the mean years since diagnosis was 4.2 ± 4.6. Thirty-nine percent of participants had 
measured blood pressure in the hypertensive range (systolic BP ≥140 mmHg or diastolic BP 
≥90 mmHg). Fewer than 1% of all participants had undergone any eye examination in the 
past year with a local ophthalmologist. No participants reported a prior history of laser, eye 
injections or surgery.  
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Age (years), mean (SD) 45.4 (9.1) 
Female, n (%) 125 (61.27) 
Weight (kg), mean (SD) 100.90 (23.93) 
HbA1c† (%), mean (SD) 7.48 (2.16) 
FBG† (mg/dl), mean (SD) 315.78 (116.31) 
BMI (kg/m2), mean (SD) 37.20 (11.56) 
Uncorrected visual acuity (logMAR), mean (SD)  0.27 (0.28) 
Corrected visual acuity (logMAR), mean (SD) 0.07 (0.15)  
Systolic BP (mm Hg), mean (SD) 131.01 (20.50) 
Diastolic BP (mm Hg), mean (SD) 85.65 (12.85) 
Hypertension, n (%)§ 77 (39.09)  
Previous hypertension diagnosis, n (%)  17 (8.72)  
Previous diabetes diagnosis, n (%)  48 (23.41) 
Years since diabetes diagnosis, ¶ 
 mean (SD) 
4.2 (4.6) 
† HbA1c, hemoglobin A1c (%); FBG, fasting blood glucose (mg/dl); SD, standard deviation; BMI, body 
mass index (kg/m2); BP, blood pressure (millimeters mercury); LogMAR, log minimum angle of 
resolution.  
‡ HbA1c: Participants 30.5 to 50 years of age (n=180). FBG: Participants more than 50 years of age 
(n=23). 
§  Hypertension = systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. 
¶  Years since the diagnosis of diabetes (n=22); a majority of participants were diagnosed at the time 
of screening.  
 
 
The Soifua Manuia Eye Screening Program 
 13 
Clinical Imaging  
 
A total of 393 eyes (95.4%) from 206 participants were successfully imaged using the 
PanOptic iExaminer. Nineteen eyes (4.6%) from 16 participants (7.8%) could not be imaged 
by the device. A total of 2,758 images were collected and submitted for remote diagnostic 
review, an average of 6.96 ± 2.94 images per eye (range: 1-18 images). All available images 
for each eye were used for clinical grading. 
 
Twenty-six percent (106/412) of eyes had at least one image graded as excellent 
overall quality, 56.1% (231/412) as good, 11.4% (47/412) as fair, and 0.2% (1/419) as 
inadequate with no structures identifiable (Figure 1). Overall, 337 eyes (81.8%) had clinically 
gradable images taken by the device. Only 54 eyes (13.1%) had a field of view that fully 
captured the macula. As expected due to the importance of image quality in successfully 
identifying pathology, there was a significant association between image quality and positive 
findings (c2=14.22 P=0.014). Of note, there was also a significant association between 
image quality and study date (F5,392=3.50, P=0.004), indicating an improvement in image 
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Figure 1. Image quality using the PanOptic iExaminer System Percent of eyes (n=412) 
with at least one fundus photo obtained within each image category: Grade 1=inadequate; 
Grade 2=fair; Grade 3=good; Grades 4 and 5=excellent. Grade 1 was assigned to images 
where the fundus was not visualized, Grade 2 images had a view of the fundus that did not 
include a full or clear view of the optic disc, Grade 3 images had a full and sharp view of the 
optic disc, Grade 4 images had a full, clear view of the optic disc in addition to some 
surrounding structures, and Grade 5 images had a full view of the optic disc in addition to 




Positive findings upon screening with the PanOptic iExaminer were identified in 
29.1% of participants (60/206) (Table 2). Features of moderate non-proliferative diabetic 
retinopathy were detected in 7 participants (3.4%), and other vascular changes related to 
diabetes and/or hypertension were found in 19 participants (9.2%). In total, 24 participants 
(11.7%) had evidence of background retinopathy (Figure 2), which was significantly 
associated with level of HbA1c (F1,176=10.48, P=0.001), corrected visual acuity (F1,190=13.50, 
P=0.0003), and BMI category (i.e. normal, overweight, obese) (c2=10.48, P=0.005) (Table 
The Soifua Manuia Eye Screening Program 
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3). There was no association between mean systolic and diastolic blood pressure and 
background retinopathy (P=0.299 and P=0.871, respectively), suggesting that the observed 
changes were likely attributable to diabetes. Additionally, there was no association between 
reported ophthalmic complaints and background retinopathy (c2=0.50, P=0.478), as 
expected due to the frequently asymptomatic nature of diabetic eye disease. No cases of 
proliferative diabetic retinopathy or clinically significant diabetic macular edema were 
identified. Importantly, the device detected additional findings in 37 participants (18.0%), 
including 33 participants (16.0%) with features suggestive of glaucoma, and 10 participants 
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Table 2. Frequency of positive findings following image review 
Findings† Eyes (%) Participants (%) 
Glaucoma suspect‡  39 (9.5) 33 (16.0)  
Retinopathy   30 (7.3) 24 (11.7)  
       Background retinopathy/hypertensive 
changes 
24 (5.8)  19 (9.2) 
       Moderate non-proliferative retinopathy   7 (1.7)   7 (3.4) 
Other  11 (2.7)  10 (4.9)  
        Myelination of nerve fiber layer  4 (1.0)  4 (1.9)  
        Choroidal lesion  1 (0.24)  1 (0.49)  
        Congenital coloboma 1 (0.24) 1 (0.49) 
        Chorioretinal degeneration 2 (0.49)  1 (0.49)  
        Lesion on optic disc  1 (0.24) 1 (0.49)  
        Morning glory disc anomaly 1 (0.24) 1 (0.49)  
        Disc tumor (e.g. angioma/meningioma) 1 (0.24) 1 (0.49)  
Total unique positive findings 75 (18.2)  60 (29.1)  
† Findings are presented as a number and percentage of total eyes (n=412) and participants (n=206). 














Figure 2. Representative fundus photographs in three participants with positive 
findings upon PanOptic iExaminer screening (A) Healthy fundus with foveal detail in a 
35-year old participant. (B) Nonproliferative diabetic retinopathy in a 65-year old participant. 
(C) Example of a glaucoma suspect (based on enlarged CDR) in a 45-year old participant. 
Lens reflexes and shadows due to camera alignment are commonly present at the edges of 
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Table 3. Associations of study population characteristics with background retinopathy  




Age (years)     0.741 
31.5-50 169 11.24  
50+ 30 13.33  
Sex   0.350 
Female 120 13.33  
Male  78 8.97  
HbA1c (%)     0.001* 
Systolic BP (mm Hg)   0.299 
Diastolic BP (mm Hg)    0.871 
Hypertension referral given§    0.994 
Yes 75 12.00  
No  117 11.97  
Body mass index (kg/m2)   0.005* 
<26 14 35.71  
26 to 32  43 13.95  
32+ 121 7.44  
Uncorrected near vision (logMAR)   0.091 
Corrected near vision (logMAR)  <0.001* 
Eye complaint¶     0.478 
Yes 128 13.28  
No 71 9.86  
 
† HbA1c, hemoglobin A1c (%); BP, blood pressure (millimeters mercury); LogMAR, log minimum 
angle of resolution 
‡ P-value represents one-way ANOVA F-test for continuous variables and c2 test for categorical 
variables.  
§ Hypertension referral given to participants presenting with either systolic blood pressure ≥140 mm 
Hg or diastolic blood pressure ≥90 mm Hg. 
¶ Patients were asked if they were experiencing any limitations with their vision or problems related to 
their eyes.   
* Statistically significant  
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There was agreement between graders for all cases of diabetic retinopathy and for 
all structural lesions identified. Formal assessment of inter-rater agreement for the features 
of the optic disc, i.e., CDR, also showed a high degree of accordance at 93.0% (Table 4). 
Subsequently, there was a moderately strong agreement for glaucoma suspect status 
(90.3% agreement) with k = 0.53 (95% CI=0.33 - 0.73), a rate of agreement similar to 
previously published studies evaluating disc photos.38 Finally, the intra-class correlation 
coefficients (ICCs) for the CDR and its difference were 0.841 (95% CI=0.81-0.87) and 0.68 
(95%CI=0.59-0.75), respectively.  
 
 
Table 4. Inter-rater reliability and agreement of image grading: optometrist versus 
ophthalmologist  
 














CDR Difference  
a 

































† CDR, cup-to-disc ratio; a: Cronbach’s alpha; ICC: intra-class correlation coefficient; CI: confidence 
interval; SD: standard deviation. 
 
 
Participants presented with an average CDR of 0.39 ± 0.11 and CDR asymmetry of -
0.01 ± 0.09, and showed no significant association with image quality (F4,174=1.05, 
P=0.382). Likewise, there was no significant association between image quality and 
glaucoma suspect status agreement (F4,378=0.85, P=0.496), or between image quality and 
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the CDR absolute difference (F4,371=0.37, P=0.830), indicating that our observed inter-rater 




Nearly half of all participants, 100 of the 206 studied (48.5%) were referred for an 
expedited consult with a local ophthalmologist as a result of the screening program. A 
positive finding on ophthalmic imaging was the reason for 61% of referrals. An additional 
19% were referred due to a participant reporting an anatomic or functional abnormality (e.g. 
prior eye trauma, floaters, visual field changes, teary or itchy eyes). A further 14% of 
participants were referred due to an inability to obtain images, likely due to cataracts, small 
pupils, or other media opacities. Finally, 6% of participants were referred due to a visual 





Our study is the first to field-test the PanOptic iExaminer System as a method of 
screening for retinal complications stemming from diabetes in a remote, resource-
constrained LMIC setting. The study screened 0.1% (206 individuals) of the total population 
of Samoa (196,440).39 We found that fundus images could be successfully obtained in 
95.4% of participants, with 81.8% of eyes having images of clinical diagnostic quality. Given 
the study was performed on participants with undilated eyes in an outdoor setting remote to 
the traditional ophthalmic clinic with limited-to-no electricity, the device performed 
remarkably well. Although more advanced non-mydriatic cameras are available, the 
durability and maintainability of the PanOptic iExaminer System in the field proved 
promising. In comparison to other fundus cameras that cost at or above $10,000, the 
The Soifua Manuia Eye Screening Program 
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PanOptic iExaminer can be acquired for well under $1,000, making this device highly 
accessible and cost-effective for use in LMICs. 
 
 Although we found that 11.7% of participants presented with background retinopathy 
changes, non-proliferative diabetic retinopathy was definitively detected in only 7 participants 
(3.4%), despite their risk status. Studies have demonstrated that diabetic retinopathy 
screening by non-ophthalmic providers achieves a lower rate of detection compared to retina 
specialists and general ophthalmologists.38 Although it is possible that the relatively low 
prevalence of diabetic retinopathy identified was a function of the device, it is also likely a 
function of the duration and severity of diabetes in the relatively young cohort of adults in the 
study.40 For example, a demographically similar study of adults between the ages of 35 to 44 
years and a diabetes duration of fewer than 10 years identified a retinopathy prevalence of 
3%.41 Importantly, the findings from the handheld non-mydriatic fundus camera used in this 
study are validated, at least in part, by clinical A1c and other biomarkers that would be 
expected to predict retinopathy (Table 3). Our study sample also proved strategic in many 
ways due to the lower prevalence of cataracts and other media opacities in this segment of 
the population, allowing for a high image capture rate (95.4%).42,43 
 
Our screening program additionally identified 16.0% of participants with glaucoma 
suspect status based solely on features identified from imaging the optic disc. Cupping of 
the optic nerve head is a hallmark for glaucomatous optic neuropathy. However, there is 
wide variation within the human population,44 and no normative data for the Samoan 
population exists. CDR asymmetry is another well-known hallmark of glaucoma and is by 
itself predictive of glaucoma prevalence.45 However, optic disc structural changes do not 
imply that a person has glaucoma, and structural features by themselves are not appropriate 
to screen for glaucoma. Furthermore, although there was a high level of grader agreement, 
allowing a glaucoma specialist to adjudicate the results could further enhance the validation 
of the instrument in comparison to a gold standard. A formal glaucoma screening program 
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should also incorporate the use of a handheld tonometer and assess for other risk factors 
associated with the disease.15 
 
The present study benefited from the use of an iPhone 6S in comparison to prior 
studies’ that employed an iPhone 3G, yielding a nearly six-fold increase in resolution.33,35 As 
smartphone technology advances, the ability to capture images in lower light with better 
detail is likely to improve.46 Furthermore, studies have illustrated the advantage of using 
fundus imaging over traditional ophthalmoscopy alone to identify retinal lesions.47 Automated 
detection and analysis of images using artificial intelligence and point-of-care decision 
support is also likely to play a role in future screening programs.9  
 
One of the most significant limitations of our study stems from the fact that the 
PanOptic iExaminer is limited to a 25° field of view, leaving unexamined the vast majority of 
the retina. Diabetic retinopathy is peripheral more than 50% of the time.48 Although the 
device likely underestimates the true burden of eye disease in Samoa and risks providing 
false assurance to patients for whom an abnormal finding was not identified, the program 
approved by the Samoan Ministry of Health exceeds the prevailing standard of care. The 
vast majority of diabetic participants screened have been unable to access eye care for a 
variety of reasons. Furthermore, the device detected the presence of many other ocular 
abnormalities in nearly one-third of our study participants, many of whom did not otherwise 
present with visual acuity limitations or other symptoms. Although we do not have access to 
the results of the ophthalmic examinations provided to participants following our screening 
program, our study successfully established a referral system. Extending the approach 
presented by building the infrastructure to allow local eye care providers to receive and 
grade images would also be a significant process improvement. Furthermore, the subset of 
individuals in our sample who are in the larger genetic and metabolic Samoan study may 
also yield useful information in directing future eye screening interventions.  
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In conclusion, it is not only the ability to screen patients for eye disease, but also the 
ability to facilitate the connection to eye care that is of paramount importance for those with 
diabetes and other conditions that pose a risk to vision.44 The present study demonstrates 
that a portable, smartphone-based non-mydriatic fundus camera can successfully be 
integrated into an eye screening program, facilitating the detection of ocular disease.  
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Figure 1. Image quality using the PanOptic iExaminer System Percent of eyes (n=412) 
with at least one fundus photo obtained within each image category: Grade 1=inadequate; 
Grade 2=fair; Grade 3=good; Grades 4 and 5=excellent. Grade 1 was assigned to images 
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where the fundus was not visualized, Grade 2 images had a view of the fundus that did not 
include a full or clear view of the optic disc, Grade 3 images had a full and sharp view of the 
optic disc, Grade 4 images had a full, clear view of the optic disc in addition to some 
surrounding structures, and Grade 5 images had a full view of the optic disc in addition to 
extensive choroidal detail and views of the both the superior and inferior vascular arcades. 
 
Figure 2. Representative fundus photographs in three participants with positive 
findings upon PanOptic iExaminer screening (A) Healthy fundus with foveal detail in a 
35-year old participant. (B) Nonproliferative diabetic retinopathy in a 65-year old participant. 
(C) Example of a glaucoma suspect (based on enlarged CDR) in a 45-year old participant. 
Lens reflexes and shadows due to camera alignment are commonly present at the edges of 
even higher quality images. 
 
Table 1. Description of the study population  
 
Table 2. Frequency of positive findings following image review 
 
Table 3. Associations of study population characteristics with background retinopathy 
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